308 related articles for article (PubMed ID: 6207976)
1. [Tumor markers. Current use in antineoplastic strategy].
Manguso L; Musset M; Coraggio F; Grimaldi G; Zito GA; Gattoni A; Catalano G; Astarita C; Papaleo G; Di Domenico M
Clin Ter; 1984 Aug; 110(3):231-41. PubMed ID: 6207976
[No Abstract] [Full Text] [Related]
2. [Tumor markers. Current knowledge and practical usefulness].
Papaleo G; Sacerdoti G; Zito GA
Recenti Prog Med; 1982 Apr; 72(4):504-30. PubMed ID: 6183719
[No Abstract] [Full Text] [Related]
3. Tumor markers.
Ewing HP; Newsom BD; Hardy JD
Curr Probl Surg; 1982 Feb; 19(2):53-94. PubMed ID: 6175486
[No Abstract] [Full Text] [Related]
4. Oncofetal and oncoplacental antigens as tumor markers.
Yamauchi S; Miyake H
Kitasato Arch Exp Med; 1988 Sep; 61(2-3):95-109. PubMed ID: 2463397
[No Abstract] [Full Text] [Related]
5. [Tumor markers in bronchial cancer: do they have a role in daily practice?].
Feintrenie X; Briancon S; Pichene M; Lamy P
Rev Pneumol Clin; 1984; 40(6):345-54. PubMed ID: 6085181
[TBL] [Abstract][Full Text] [Related]
6. [An overview of tumor markers].
Morita R; Fukunaga M; Ohtsuka N
Rinsho Hoshasen; 1986 Jan; 31(1):1-10. PubMed ID: 2422414
[No Abstract] [Full Text] [Related]
7. [Significance of tumor markers in clinical oncology].
Gericke D; Drahovsky D
Med Klin; 1979 May; 74(19):701-9. PubMed ID: 88005
[No Abstract] [Full Text] [Related]
8. [Diagnosis of tumors with the use of immunologic tumor markers].
Vorlaender KO
Wien Med Wochenschr; 1983 Feb; 133(3):59-66. PubMed ID: 6189301
[No Abstract] [Full Text] [Related]
9. [Immunologic diagnosis of malignant neoplasms. II].
Shuster J; Thomson DM; Fuks A; Gold P
Union Med Can; 1980 Jul; 109(7):1063-74. PubMed ID: 6162263
[No Abstract] [Full Text] [Related]
10. Diagnostic significance and clinical application of tumour-associated antigens in man with special reference to the carcinoembryonic antigen.
Wagener C; Breuer H
J Clin Chem Clin Biochem; 1977 Oct; 15(10):529-43. PubMed ID: 72783
[No Abstract] [Full Text] [Related]
11. The use of carcinoembryonic antigen and peptide hormones to stage and monitor patients with lung cancer.
Gropp C; Havemann K; Scheuer A
Int J Radiat Oncol Biol Phys; 1980 Aug; 6(8):1047-53. PubMed ID: 6252125
[No Abstract] [Full Text] [Related]
12. [Tissue polypeptide antigen. A new serum marker in pulmonary carcinoma].
Purello D'Ambrosio F; Angiò LG; Ruggeri P
Minerva Med; 1989 Jul; 80(7):687-8. PubMed ID: 2476686
[No Abstract] [Full Text] [Related]
13. [Diagnosis of malignant diseases using tumor markers].
Schneider J
Biomed Tech (Berl); 1984 Nov; 29(11):278-82. PubMed ID: 6210115
[No Abstract] [Full Text] [Related]
14. Biochemical and immunochemical markers associated with cancer.
Schwartz MK
Clin Bull; 1976; 6(2):62-8. PubMed ID: 59641
[No Abstract] [Full Text] [Related]
15. [Humoral markers in thyroid carcinoma].
Pinchera A; Pacini F; Martino E; Anelli S
Minerva Med; 1986 Nov; 77(44):2089-91. PubMed ID: 3785723
[No Abstract] [Full Text] [Related]
16. [Clinical evaluation of serum tissue polypeptide antigen in various cancers].
Wang WM; Chen CY; Wu CC; Jan CM; Wang GC; Chen JY; Lan TS; Chen LT; Su LN; Her SS
Taiwan Yi Xue Hui Za Zhi; 1988 May; 87(5):569-73. PubMed ID: 2458426
[No Abstract] [Full Text] [Related]
17. [Radioimmunoassays in oncology].
Dressler J
Fortschr Med; 1983 Mar; 101(11):451-4. PubMed ID: 6189774
[TBL] [Abstract][Full Text] [Related]
18. Tumor markers. Key pieces to your cancer patient's clinical picture.
Ostchega Y; Culnane M
Nursing; 1985 Sep; 15(9):48-51. PubMed ID: 2410836
[No Abstract] [Full Text] [Related]
19. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms].
Ławicki S; Mroczko B; Szmitkowski M
Postepy Hig Med Dosw; 2002; 56(5):617-34. PubMed ID: 12596691
[TBL] [Abstract][Full Text] [Related]
20. Immunologic tests in diagnosis of cancer.
Herberman RB
Am J Clin Pathol; 1977 Nov; 68(5 Suppl):688-98. PubMed ID: 72502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
